vs
Side-by-side financial comparison of OP Bancorp (OPBK) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
OP Bancorp is the larger business by last-quarter revenue ($24.3M vs $18.3M, roughly 1.3× ROCKWELL MEDICAL, INC.). On growth, OP Bancorp posted the faster year-over-year revenue change (13.7% vs -25.6%). OP Bancorp produced more free cash flow last quarter ($23.4M vs $2.2M). Over the past eight quarters, OP Bancorp's revenue compounded faster (11.4% CAGR vs -10.1%).
OP Bancorp is the bank holding company for Open Bank, a community-oriented commercial bank headquartered in California, United States. It provides a full range of banking solutions including deposit accounts, commercial real estate loans, small business financing, and consumer lending products, primarily catering to small and medium-sized enterprises, local immigrant communities, and retail clients across Southern California.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
OPBK vs RMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $24.3M | $18.3M |
| Net Profit | — | $-554.0K |
| Gross Margin | — | 21.1% |
| Operating Margin | 39.2% | -2.2% |
| Net Margin | — | -3.0% |
| Revenue YoY | 13.7% | -25.6% |
| Net Profit YoY | — | 26.7% |
| EPS (diluted) | $0.48 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $24.3M | $18.3M | ||
| Q3 25 | $24.5M | $15.9M | ||
| Q2 25 | $23.7M | $16.1M | ||
| Q1 25 | $22.2M | $18.9M | ||
| Q4 24 | $21.3M | $24.7M | ||
| Q3 24 | $20.7M | $28.3M | ||
| Q2 24 | $20.4M | $25.8M | ||
| Q1 24 | $19.6M | $22.7M |
| Q4 25 | — | $-554.0K | ||
| Q3 25 | $6.7M | $-1.8M | ||
| Q2 25 | $6.3M | $-1.5M | ||
| Q1 25 | $5.6M | $-1.5M | ||
| Q4 24 | — | $-756.0K | ||
| Q3 24 | $5.4M | $1.7M | ||
| Q2 24 | $5.4M | $343.0K | ||
| Q1 24 | $5.2M | $-1.7M |
| Q4 25 | — | 21.1% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 16.1% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | — | 17.6% | ||
| Q1 24 | — | 13.5% |
| Q4 25 | 39.2% | -2.2% | ||
| Q3 25 | 39.5% | -9.9% | ||
| Q2 25 | 35.7% | -8.4% | ||
| Q1 25 | 34.6% | -7.2% | ||
| Q4 24 | 31.2% | -2.1% | ||
| Q3 24 | 36.5% | 6.8% | ||
| Q2 24 | 37.2% | 2.0% | ||
| Q1 24 | 37.1% | -5.8% |
| Q4 25 | — | -3.0% | ||
| Q3 25 | 27.4% | -11.0% | ||
| Q2 25 | 26.7% | -9.3% | ||
| Q1 25 | 25.0% | -8.0% | ||
| Q4 24 | — | -3.1% | ||
| Q3 24 | 26.2% | 5.9% | ||
| Q2 24 | 26.7% | 1.3% | ||
| Q1 24 | 26.7% | -7.6% |
| Q4 25 | $0.48 | $-0.01 | ||
| Q3 25 | $0.45 | $-0.05 | ||
| Q2 25 | $0.42 | $-0.05 | ||
| Q1 25 | $0.37 | $-0.04 | ||
| Q4 24 | $0.33 | $-0.02 | ||
| Q3 24 | $0.36 | $0.04 | ||
| Q2 24 | $0.36 | $0.01 | ||
| Q1 24 | $0.34 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.3M | $10.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $227.9M | $37.0M |
| Total Assets | $2.7B | $57.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.3M | $10.7M | ||
| Q3 25 | $166.7M | $13.6M | ||
| Q2 25 | $205.4M | $12.5M | ||
| Q1 25 | $198.9M | $11.4M | ||
| Q4 24 | $134.9M | $15.7M | ||
| Q3 24 | $166.8M | $12.3M | ||
| Q2 24 | $127.7M | $11.9M | ||
| Q1 24 | $139.2M | $6.6M |
| Q4 25 | $227.9M | $37.0M | ||
| Q3 25 | $221.5M | $37.0M | ||
| Q2 25 | $213.7M | $30.4M | ||
| Q1 25 | $210.1M | $31.5M | ||
| Q4 24 | $205.0M | $32.6M | ||
| Q3 24 | $203.6M | $29.1M | ||
| Q2 24 | $195.9M | $23.5M | ||
| Q1 24 | $194.7M | $20.6M |
| Q4 25 | $2.7B | $57.1M | ||
| Q3 25 | $2.6B | $57.5M | ||
| Q2 25 | $2.6B | $52.6M | ||
| Q1 25 | $2.5B | $54.0M | ||
| Q4 24 | $2.4B | $59.2M | ||
| Q3 24 | $2.4B | $57.1M | ||
| Q2 24 | $2.3B | $53.0M | ||
| Q1 24 | $2.2B | $50.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.2M | $2.3M |
| Free Cash FlowOCF − Capex | $23.4M | $2.2M |
| FCF MarginFCF / Revenue | 96.2% | 12.0% |
| Capex IntensityCapex / Revenue | 11.5% | 0.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $43.3M | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.2M | $2.3M | ||
| Q3 25 | $23.9M | $-1.3M | ||
| Q2 25 | $-7.0M | $1.8M | ||
| Q1 25 | $5.6M | $-3.5M | ||
| Q4 24 | $31.2M | $865.0K | ||
| Q3 24 | $13.3M | $4.3M | ||
| Q2 24 | $15.8M | $1.4M | ||
| Q1 24 | $-3.2M | $-2.4M |
| Q4 25 | $23.4M | $2.2M | ||
| Q3 25 | $23.4M | $-1.5M | ||
| Q2 25 | $-7.7M | $1.7M | ||
| Q1 25 | $4.2M | $-3.5M | ||
| Q4 24 | $29.7M | $470.0K | ||
| Q3 24 | $12.8M | $4.1M | ||
| Q2 24 | $15.7M | $1.2M | ||
| Q1 24 | $-3.2M | $-2.5M |
| Q4 25 | 96.2% | 12.0% | ||
| Q3 25 | 95.6% | -9.6% | ||
| Q2 25 | -32.5% | 10.5% | ||
| Q1 25 | 19.0% | -18.8% | ||
| Q4 24 | 139.0% | 1.9% | ||
| Q3 24 | 61.5% | 14.4% | ||
| Q2 24 | 77.0% | 4.5% | ||
| Q1 24 | -16.6% | -11.1% |
| Q4 25 | 11.5% | 0.5% | ||
| Q3 25 | 2.3% | 1.4% | ||
| Q2 25 | 3.0% | 1.0% | ||
| Q1 25 | 6.4% | 0.3% | ||
| Q4 24 | 7.3% | 1.6% | ||
| Q3 24 | 2.8% | 0.7% | ||
| Q2 24 | 0.4% | 1.1% | ||
| Q1 24 | 0.5% | 0.6% |
| Q4 25 | — | — | ||
| Q3 25 | 3.57× | — | ||
| Q2 25 | -1.10× | — | ||
| Q1 25 | 1.02× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.45× | 2.57× | ||
| Q2 24 | 2.90× | 4.20× | ||
| Q1 24 | -0.60× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OPBK
Segment breakdown not available.
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
